Clinical trial
Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With…
NCT00082251 · Kos Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00082251 |
|---|---|
| Title | Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST |
| Official title | Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST |
| Lead sponsor | Kos Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Niacin extended release and simvastatin tablets |
| First posted | May 5, 2004 |
| Last update posted | Nov 1, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: